Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001014763-12-000013
Filing Date
2012-05-15
Accepted
2012-05-15 11:49:12
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 3-31-12 form10q_03312012.htm 10-Q 321599
2 EXHIBIT 31.1A 3-31-12 exhibit31-1a_03312012.htm EX-31.1A 12080
3 EXHIBIT 31.1B 3-31-12 exhibit31-1b_03312012.htm EX-31.1B 11882
4 EXHIBIT 32.1 3-31-12 exhibit32-1_03312012.htm EX-32.1 8064
  Complete submission text file 0001014763-12-000013.txt   1359641

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS 3-31-12 amar-20120331.xml EX-101.INS 115279
6 EXHIBIT 101.SCH 3-31-12 amar-20120331.xsd EX-101.SCH 13864
7 EXHIBIT 101.CAL 3-31-12 amar-20120331_cal.xml EX-101.CAL 19132
8 EXHIBIT 101.DEF 3-31-12 amar-20120331_def.xml EX-101.DEF 70064
9 EXHIBIT 101.LAB 3-31-12 amar-20120331_lab.xml EX-101.LAB 86624
10 EXHIBIT 101.PRE 3-31-12 amar-20120331_pre.xml EX-101.PRE 70932
Mailing Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225
Business Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225 (806) 376-1741
AMARILLO BIOSCIENCES INC (Filer) CIK: 0001014763 (see all company filings)

EIN.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20791 | Film No.: 12842327
SIC: 2834 Pharmaceutical Preparations